Código QR (código de barras bidimensional)

Comparison of Neoadjuvant Chemotherapy Efficiency in Advanced Ovarian Cancer Patients Treated With Paclitaxel Plus Carboplatin and Intraperitoneal Bevacizumab vs. Paclitaxel With Carboplatin

ObjectiveThis study evaluated the role of neoadjuvant chemotherapy (NACT) with bevacizumab intraperitoneal perfusion in advanced ovarian cancer (AOC).MethodsIn this study, 80 patients with advanced epithelial ovarian cancer (stage IIIc or IV) who received NACT at the Central Hospital of Zhuzhou betw...

תיאור מלא

שמור ב:
Principais autores: Yin Tao, Xue-Ting Tang, Xing Li, An-Shan Wu, Hou-Shen Zhou, Cheng-fang Zhou
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2022-03-01
סדרה:Frontiers in Medicine
נושאים:
neoadjuvant chemotherapy
bevacizumab
intraperitoneal perfusion
advanced ovarian cancer
R0 resection
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fmed.2022.807377/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים